Town of Clayton Unveils Collaboration with Novo Nordisk

A public-private partnership has cut the ribbon for a regional industrial wastewater pretreatment facility in Clayton worth $40 million.

Ribbon Cutting for R. Steven Biggs Regional Wastewater Pretreatment Facility
Ribbon Cutting for R. Steven Biggs
Regional Wastewater Pretreatment Facility

The facility was unanimously accepted by the Clayton Town Council as a donation from Novo Nordisk. Mayor Jody McLeod joined Novo Nordisk Corporate Vice President Chad Henry, and state and Johnston County leaders, including State Senator Brent Jackson and Representative Donna White, to celebrate the completion of the R. Steven Biggs Regional Wastewater Pretreatment Facility.

The facility will serve Novo Nordisk’s active pharmaceutical ingredient manufacturing facility with the potential to include other companies in the North Carolina BioPharma Crescent region.

The treatment plant was built to be an economic driver for the entire region. Its modular design will allow flexibility and expansion capacity to treat 450,000 gallons of industrial wastewater per day for current and future biopharma partners who will be able to plug in.

R. Steven Biggs Regional Wastewater Pretreatment Facility
R. Steven Biggs Regional Wastewater Pretreatment Facility

$10 million of support was funded by the Golden LEAF Foundation and the NC General Assembly. The Golden LEAF Foundation awarded the infrastructure funding to attract business to the region. The NC General Assembly, NC Department of Commerce, NC Department of Environmental Quality, US Economic Development Administration, Johnston County, local industry leaders and Clayton Town Council said they have all recognized the value of this historic cooperative, regional solution.

The the R. Steven Biggs Regional Wastewater Pretreatment Facility is named for the former Clayton town manager. The designation was to recognize Biggs' vision to recognize such public-private partnerships to drive the economy of Clayton and the rest of North Carolina.

 

 

Lindsey Baron, NCBiotech Writer
Mon, 10/14/2019 - 16:02